Company / Book Value per Share
PALVELLA THERAPEUTICS, INC. Book Value per Share History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
$28.126
FY2024
5-year range
-$1.298 / $28.126
FY2020-FY2024
Trend
+2914.0%
vs FY2023
Sector context
#16 of 209
Health Care
What the data says
Book Value per Share changed +2914% YoY in FY2024, a notable deviation from the 9-year average annual change of +299%.
Based on SEC 10-K filings.
$28.126 in FY2024 with a 5-year CAGR of +97.0%. Top quartile in the Health Care sector.
Improved from -$1.298 to $28.126 over the past 2 years.
Health Care sector context is included.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- +270.3%
- 5-Year CAGR
- +97.0%
- 10-Year CAGR
- -
Sector benchmark
Top 8% in Health CareTop 8% of 209This company $28.126 Sector average $215.686
▼
-87.0% below sector average
Key checks
Key Insights
- 5-year CAGR of +97.0%, indicating consistent growth.
- In FY2024, book value per share increased 2914.0% year-over-year.
- Ranks #16 out of 209 companies in the Health Care sector.
- Lowest book value per share in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score 1.15 (distress zone, below 1.8 threshold)
- Strong profit margin: 43.7%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $28.126 | +2914.0% |
| FY2023 | -$1 | +23.0% |
| FY2022 | -$1.298 | -334.4% |
| FY2021 | $0.554 | -40.4% |
| FY2020 | $0.93 | -1.9% |
| FY2019 | $0.948 | +270.5% |
| FY2018 | $0.256 | -56.3% |
| FY2017 | $0.586 | -7.5% |
| FY2016 | $0.633 | -71.8% |
| FY2015 | $2.245 | +47.5% |
As of FY2024 · SEC 10-K Annual Filings · Updated Jun 30, 2026